Healthcare -
Biotechnology - NASDAQ - US
$ 0.3243
-0.46 %
$ 18.8 M
Market Cap
-0.19
P/E
BCAB - STOCK-BASED COMPENSATION
Stock-based Compensation BCAB - BioAtla, Inc.
13.5 M
LAST VALUE
-26.57%
2 YEAR CAGR
452.24%
5 YEAR CAGR
0.00%
10 YEAR CAGR